MICROVASCULAR THERAPEUTICS

microvascular-therapeutics-logo

A biotechnology company based in Tucson, Arizona .

#People #Financial #Website #More

MICROVASCULAR THERAPEUTICS

Industry:
Biotechnology Medical

Founded:
2016-01-01

Address:
Tucson, Arizona, United States

Country:
United States

Website Url:
http://www.mvtpharma.com

Total Employee:
1+

Status:
Active

Total Funding:
1.6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail GoDaddy DNS


Current Employees Featured

wyatt-unger_image

Wyatt Unger
Wyatt Unger Chief Executive Officer and Chief Medical Officer @ Microvascular Therapeutics
Chief Executive Officer and Chief Medical Officer
2015-11-01

dr-evan-c-unger_image

Dr. Evan C. Unger
Dr. Evan C. Unger Founder, Interim Chief Executive Officer and Consultant @ Microvascular Therapeutics
Founder, Interim Chief Executive Officer and Consultant

emmanuelle-j-meuillet_image

Emmanuelle J. Meuillet
Emmanuelle J. Meuillet Chief Scientific Officer @ Microvascular Therapeutics
Chief Scientific Officer
2020-01-01

Founder


dr-evan-c-unger_image

Dr. Evan C. Unger

Investors List

national-heart-lung-and-blood-institute_image

National Heart, Lung and Blood Institute

National Heart, Lung and Blood Institute investment in Grant - Microvascular Therapeutics

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - Microvascular Therapeutics

Official Site Inspections

http://www.mvtpharma.com Semrush global rank: 5.67 M Semrush visits lastest month: 1.48 K

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Microvascular Therapeutics"

MVT Pharma: Pioneers in ultrasound contrast and theranostics.

Microvascular Therapeutics (MVT) is a biotechnology company specializing in the development of microbubble and nanotechnology products for the diagnosis and treatment of disease.See details»

Microvascular Therapeutics - LinkedIn

Microvascular Therapeutics (MVT) is developing a new improved ultrasound contrast agent MVT-100 via the 505 (b) (2) pathway. The founders of MVT developed Definityยฎ, the worldโ€™s #1 โ€ฆSee details»

Microvascular Therapeutics welcomes Thom Tulip as Chief โ€ฆ

Feb 8, 2024ย ยท Microvascular Therapeutics is a clinical-stage biotechnology company based in Tucson, Arizona, leading in microbubble and nanobubble technology. MVT's mission is to โ€ฆSee details»

Microvascular Therapeutics - Crunchbase Company Profile

Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis. View contacts for Microvascular Therapeutics to access new leads โ€ฆSee details»

Microvascular Therapeutics - PitchBook

Developer of ultrasound contrast and theranostics products intended for cancer and heart disease.See details»

Microvascular Therapeutics Welcomes Thom Tulip as Chief โ€ฆ

Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company at the forefront of developing the next generation of microbubbles unlocking the therapeutic potential of โ€ฆSee details»

Microvascular Therapeutics | BioPharm America - Informa Connect

Microvascular Therapeutics is a clinical stage biopharma company pioneering in ultrasound contrast agents and theranostics. The company is further advancing a Phase I/II asset (MVT โ€ฆSee details»

Microvascular Therapeutics and Cordance Medical Announce โ€ฆ

Sep 16, 2024ย ยท MVT has developed a new, patented microbubble that serves as a platform for developing agents for molecular imaging and image-guided therapy. For more information, โ€ฆSee details»

Microvascular Therapeutics - Company Profile & Staff Directory

Microvascular Therapeutics is a clinical stage biotechnology which pioneers in ultrasound contrast agents and theranostics. Microvascular Therapeutics (MVT) is developing a new improved โ€ฆSee details»

Microvascular Therapeutics, LLC - CMOCRO

Private/Public: private Company Contact: Wyatt Unger Phone: 520.624.6688 Email: [email protected] Website: https://www.mvtpharma.com/ Address: 1635 E 18th St., Tucson, AZ โ€ฆSee details»

Microvascular Therapeutics - VentureRadar

Website: https://www.mvtpharma.com/ Develops advanced contrast agents for diagnostic ultrasound, enhancing imaging accuracy and enabling better detection of medical conditions. โ€ฆSee details»

Microvascular Therapeutics Selected as a Participant in the 2023 โ€ฆ

Dec 12, 2023ย ยท Microvascular Therapeutics (MVT), a clinical stage biopharma pioneering the potential of ultrasound in diagnostics and theranostics, has been selected to join the โ€ฆSee details»

Microvascular Therapeutics - Overview, News & Similar

Dec 13, 2023ย ยท Microvascular Therapeutics contact info: Phone number: (520) 624-6688 Website: www.mvtpharma.com What does Microvascular Therapeutics do? About Microvascular โ€ฆSee details»

Microvascular Therapeutics Has Received Funds from the ... - PR.com

The chemists at MVT have developed a new, patented microbubble formulation that can serve as a platform for development of agents for molecular imaging and image-guided therapy....See details»

MVT: In the News - MVT Pharma

Dec 12, 2023ย ยท Microvascular Therapeutics (MVT) is a biotechnology company specializing in the development of microbubble and nanotechnology products for the diagnosis and treatment of โ€ฆSee details»

Microvascular Therapeutics Welcomes Thom Tulip as Chief โ€ฆ

Feb 10, 2024ย ยท MVT has pioneered a new, patented microbubble serving as a platform for developing agents for molecular imaging and image-guided therapy. Learn more at โ€ฆSee details»

Microvascular Therapeutics selected as a Participant in the 2024 ...

Feb 9, 2024ย ยท MVT has developed a new, patented microbubble that serves as a platform for the development of agents for molecular imaging and image-guided therapy. Learn more at โ€ฆSee details»

Microvascular Therapeutics Finalizes Facility Certification for the ...

Apr 21, 2022ย ยท Microvascular Therapeutics Finalizes Facility Certification for the Production of MVT-100. Tucson, AZ & Mountain View, CA โ€“ Microvascular Therapeutics (MVT), a โ€ฆSee details»

MVT Pharma: Journals

We are developing a novel treatment, termed sonoreperfusion (SRP), to restore microvascular patency. This entails using ultrasound-targeted microbubble cavitation (UTMC) of โ€ฆSee details»

linkstock.net © 2022. All rights reserved